scholarly article | Q13442814 |
P50 | author | Ralph Weissleder | Q7288259 |
P2093 | author name string | John W Chen | |
Elisenda Rodríguez | |||
Mark Nilges | |||
P2860 | cites work | Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes | Q28359694 |
Myeloperoxidase: friend and foe | Q29619070 | ||
Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment | Q30635335 | ||
The synthesis and in vitro testing of a zinc-activated MRI contrast agent | Q31122779 | ||
Mechanisms of ZnII-activated magnetic resonance imaging agents | Q33377534 | ||
Bioresponsive, cell-penetrating, and multimeric MR contrast agents | Q33470566 | ||
Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis | Q33708751 | ||
Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ? | Q33927624 | ||
Association between myeloperoxidase levels and risk of coronary artery disease | Q34100405 | ||
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions | Q34236265 | ||
Prognostic value of myeloperoxidase in patients with chest pain | Q34271813 | ||
Growing significance of myeloperoxidase in non-infectious diseases. | Q34578402 | ||
Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins | Q34749406 | ||
Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver | Q35747219 | ||
Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates | Q36545615 | ||
Oxidative stress, lipid rafts, and macrophage reprogramming | Q36885673 | ||
Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase | Q36985114 | ||
Inhibition of reactive oxygen species down-regulates protein synthesis in RAW 264.7. | Q39981131 | ||
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study | Q40196845 | ||
Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. | Q41864110 | ||
Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques | Q42543316 | ||
Kinetic evidence for rapid oxidation of (-)-epicatechin by human myeloperoxidase | Q43441240 | ||
Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase | Q44301559 | ||
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill | Q44302226 | ||
Neuronal expression of myeloperoxidase is increased in Alzheimer's disease | Q44980217 | ||
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. | Q45297626 | ||
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis | Q48615832 | ||
Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism | Q48772351 | ||
Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations | Q54462461 | ||
Lanthanide-Loaded Paramagnetic Liposomes as Switchable Magnetically Oriented Nanovesicles | Q58830297 | ||
Further evidence for the role of myeloperoxidase in the activation of benzo[a]pyrene-7,8-dihydrodiol by polymorphonuclear leukocytes | Q68244401 | ||
Antimicrobial activity of myeloperoxidase | Q70214734 | ||
A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians | Q74293599 | ||
Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase | Q77580985 | ||
Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production | Q77604789 | ||
Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis | Q80089503 | ||
Kinetics of phenolic polymerization catalyzed by peroxidase in organic media | Q81633235 | ||
DTPA-bisamide-based MR sensor agents for peroxidase imaging | Q81674771 | ||
A paramagnetic contrast agent with myeloperoxidase-sensing properties | Q83318371 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 168-177 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Journal of the American Chemical Society | Q898902 |
P1476 | title | Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity | |
P478 | volume | 132 |
Q37669759 | A Janus Chelator Enables Biochemically Responsive MRI Contrast with Exceptional Dynamic Range |
Q30562239 | A novel paramagnetic substrate for detecting myeloperoxidase activity in vivo. |
Q27009286 | A review of responsive MRI contrast agents: 2005-2014 |
Q33823740 | Activatable T₁ and T₂ magnetic resonance imaging contrast agents |
Q26863117 | Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine |
Q92255078 | An activatable PET imaging radioprobe is a dynamic reporter of myeloperoxidase activity in vivo |
Q64926634 | An enzyme-activatable and cell-permeable MnIII-porphyrin as a highly efficient T1 MRI contrast agent for cell labeling. |
Q34381265 | Bioengineered probes for molecular magnetic resonance imaging in the nervous system |
Q38420827 | Bioresponsive probes for molecular imaging: concepts and in vivo applications |
Q38785651 | Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy |
Q57814135 | Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers |
Q35896745 | Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. |
Q27021691 | Detecting enzyme activities with exogenous MRI contrast agents |
Q33712697 | Development of Responsive Lanthanide-Based Magnetic Resonance Imaging and Luminescent Probes for Biological Applications |
Q35091322 | Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging. |
Q55109334 | High-resolution Imaging of Myeloperoxidase Activity Sensors in Human Cerebrovascular Disease. |
Q39324383 | In vivo examination of 111In-bis-5HT-DTPA to target myeloperoxidase in atherosclerotic ApoE knockout mice |
Q31136705 | Interrogating Metabolism in Brain Cancer. |
Q40232962 | Kinetic investigation of myeloperoxidase upon interaction with copper, cadmium, and lead ions. |
Q27306416 | Ligation of the jugular veins does not result in brain inflammation or demyelination in mice |
Q30868199 | MR imaging probes: design and applications |
Q38736725 | Methods for measuring myeloperoxidase activity toward assessing inhibitor efficacy in living systems. |
Q38090583 | Molecular MRI of the Cardiovascular System in the Post-NSF Era |
Q92383461 | Molecular Magnetic Resonance Imaging Using a Redox-Active Iron Complex |
Q90590295 | Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances |
Q30454154 | Molecular body imaging: MR imaging, CT, and US. part I. principles |
Q27687291 | Molecular imaging for cancer diagnosis and surgery |
Q38204374 | Molecular imaging of macrophage enzyme activity in cardiac inflammation. |
Q36867835 | Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice |
Q88886710 | Multimodal Molecular Imaging Demonstrates Myeloperoxidase Regulation of Matrix Metalloproteinase Activity in Neuroinflammation |
Q36630212 | Myeloperoxidase Nuclear Imaging for Epileptogenesis |
Q35143525 | Myeloperoxidase propagates damage and is a potential therapeutic target for subacute stroke |
Q34987068 | Nanoparticle preconditioning for enhanced thermal therapies in cancer |
Q30576477 | Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy. |
Q37591328 | Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. |
Q41550912 | Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway. |
Q47151833 | Spinal Cord Inflammation: Molecular Imaging after Thoracic Aortic Ischemia Reperfusion Injury. |
Q37873318 | Strategies for in vivo imaging of enzyme activity: an overview and recent advances |
Q35777941 | Strategies for the preparation of bifunctional gadolinium(III) chelators |
Q39606257 | Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma |
Q30240734 | The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture. |
Q34074677 | Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase. |